Laboratory

The result of a blood culture test examining blood for the presence of bacteria or fungi, reported as no growth after the incubation period or positive with identification of the isolated organism and antimicrobial susceptibility results. Blood culture result is the gold standard for bacteremia and sepsis diagnosis, with time to positivity and organism identification informing antibiotic de-escalation decisions in critically ill patients.

A measurement of blood pH from arterial, venous, or capillary blood gas analysis, reflecting the acid-base balance of the blood with a normal arterial range of 7.35-7.45. Blood gas pH is used in critical care management of respiratory failure, metabolic acidosis from diabetic ketoacidosis or lactic acidosis, and metabolic alkalosis. Serial pH measurements guide mechanical ventilator settings and bicarbonate administration in acid-base disorder management.

A laboratory measurement of urea nitrogen concentration in blood, expressed in mg/dL, reflecting kidney function and protein catabolism. Blood urea nitrogen is included in Basic and Comprehensive Metabolic Panels and is used with serum creatinine to calculate the BUN-to-creatinine ratio for differentiating prerenal, intrinsic renal, and postrenal causes of acute kidney injury.

A laboratory measurement of B-type natriuretic peptide in blood, expressed in pg/mL, used as a biomarker for heart failure diagnosis, severity assessment, and treatment monitoring. BNP is released by ventricular myocytes in response to pressure and volume overload, with elevated levels above 100 pg/mL supporting heart failure diagnosis. BNP-guided therapy protocols use serial measurements to optimize diuretic and neurohormonal therapy in chronic heart failure management.

The elapsed time in minutes between specimen collection and final result reporting, the primary laboratory turnaround time metric used to assess laboratory efficiency, monitor compliance with turnaround time standards for routine and stat testing, identify processing bottlenecks, and benchmark performance against regulatory and accreditation requirements. This is the standard metric used in CAP and Joint Commission laboratory accreditation assessments.

A flag identifying that a laboratory result has been amended or corrected after initial reporting, requiring clinical notification of the ordering provider and documentation of the reason for correction such as transcription error, instrument malfunction, or sample mix-up. Laboratories must maintain records of all result corrections, and downstream data systems must update records to reflect the corrected value while preserving audit history of the original result.

A flag identifying that a laboratory result has reached a life-threatening threshold requiring immediate notification of the ordering clinician, such as a potassium below 2.5 or above 6.5 mEq/L, glucose below 40 mg/dL, or troponin above institutional critical threshold. Critical value notification is a patient safety requirement tracked in laboratory quality metrics with documentation of notification time and provider required for accreditation compliance.

Binary flag indicating whether a microbiology culture test is currently active within the laboratory information system. Used to filter active versus inactive culture orders in clinical workflows, quality reporting, and lab result tracking across inpatient and outpatient settings.

Categorical status value representing the current activity state of a microbiology culture test, such as pending, in-progress, resulted, or cancelled. Supports laboratory workflow management and enables downstream clinical decision-making based on specimen processing stage.

Physical or facility location string associated with a microbiology culture test order or result record in EHR and laboratory information systems. Identifies where the specimen was collected, processed, or reported, supporting chain-of-custody tracking, public health reporting integrations, and downstream analytics on infection site distributions across clinical data warehouses.

Monetary value representing a financial adjustment applied to a microbiology culture test charge, such as a contractual write-off, payer discount, or billing correction. Used in revenue cycle management to reconcile billed charges against actual reimbursement on lab claims.

The elapsed time, typically in hours or days, since a microbiology culture specimen was initiated or inoculated. Used in laboratory workflows to monitor incubation duration, flag overdue results, and ensure timely reporting of pathogen growth within clinical turnaround standards.

The maximum dollar amount a payer will reimburse for a microbiology culture test based on the contracted fee schedule or benefit plan. Used in claims adjudication and revenue cycle reporting to determine payer liability and calculate patient cost-sharing obligations.

Monetary value field representing the charge, reimbursement, or cost associated with a microbiology culture test within laboratory billing, claims, and EHR systems. Used in revenue cycle management platforms to capture CPT-coded lab service fees, reconcile payer remittance amounts, and support downstream financial analytics for clinical laboratory operations.

The authorization state of a microbiology culture test order, indicating whether the test has been approved, denied, or is pending review. Used in prior authorization workflows and utilization management to ensure payer or clinical approval before specimen processing begins.

Identifier or name of the clinician, supervisor, or system user who authorized a microbiology culture test order or result. Used in laboratory audit trails to maintain chain-of-custody documentation and support regulatory compliance with result verification requirements.

The timestamp recording when a microbiology culture specimen physically arrived at the laboratory for processing. Used to calculate specimen turnaround time, monitor pre-analytical delays, and ensure compliance with lab accreditation standards for timely specimen handling.

The calendar date on which a microbiology culture specimen was received at the processing laboratory. Used in laboratory information systems to establish the start of the testing timeline, support quality metrics, and document chain-of-custody for specimen integrity verification.

The clinician's or microbiologist's narrative or structured evaluation of a microbiology culture result, including interpretation of organism growth, sensitivity patterns, and clinical significance. Used to guide treatment decisions and communicate findings within the patient's clinical record.

Outstanding financial amount remaining on a microbiology culture test account after payments, adjustments, or insurance remittance have been applied within laboratory billing and revenue cycle systems. Tracked in EHR and claims platforms to manage patient receivables, trigger collections workflows, and support accounts receivable aging reports for clinical laboratory services.